Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Teriparatide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,626,720Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Forteo

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2020 Revenue in Millions : 1,046

    2019 Revenue in Millions : 1,405

    Growth (%) : -26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2021 Revenue in Millions : 802

    2020 Revenue in Millions : 1,046

    Growth (%) : -23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2022 Revenue in Millions : 613

    2021 Revenue in Millions : 802

    Growth (%) : -24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2023 Revenue in Millions : 533

    2022 Revenue in Millions : 613

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Bone Health

    Currency : USD

    2015 Revenue in Millions : 1,322

    2014 Revenue in Millions : 1,348

    Growth (%) : 2%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Bone Health

    Currency : USD

    2014 Revenue in Millions : 6.20%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Bone Health

    Currency : USD

    2016 Revenue in Millions : 1,500

    2015 Revenue in Millions : 1,348

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Bone and Joint Diseases

    Currency : USD

    2017 Revenue in Millions : 1,749

    2016 Revenue in Millions : 1,500

    Growth (%) : 17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Bone And Joint Diseases

    Currency : USD

    2018 Revenue in Millions : 1,576

    2017 Revenue in Millions : 1,749

    Growth (%) : -10%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Forteo

    Teriparatide

    arrow
    Fi Europe 2024
    Not Confirmed

    Brand Name : Forteo

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed

    Eli Lilly

    Teriparatide

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2019 Revenue in Millions : 1,405

    2018 Revenue in Millions : 1,576

    Growth (%) : -11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF